Impact of using less objective symptoms to define tolerated dose during food challenges: A data-driven approach (2023)
Attributed to:
Exploring mechanisms to optimise the duration of oral immunotherapy for peanut allergy
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/j.jaci.2022.12.818
Publication URI: http://dx.doi.org/10.1016/j.jaci.2022.12.818
Type: Journal Article/Review
Parent Publication: Journal of Allergy and Clinical Immunology
Issue: 1